Log In
Print
BCIQ
Print
Print this Print this
 

LY2951742

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionHumanized mAb targeting calcitonin gene-related peptide (CGRP)
Molecular Target Calcitonin gene-related peptide (CGRP)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase III
Standard IndicationMigraine
Indication DetailsPrevent episodic migraine; Treat cluster headaches
Regulatory Designation

U.S. - Fast Track (Treat cluster headaches)

Partner


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today